Clinical Trial Update: A Phase I Trial of 5-Fluorouracil Given With 776C85 (GW776) and Low-Dose Leucovorin in Adult Patients With Solid Tumors [Phase 1]

View source ↗

Summary

This is a completed Phase I trial evaluating the safety of combining 5-fluorouracil with GW776 and low-dose leucovorin in adults with solid tumors, sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Neoplasms

Drugs mentioned

• 5-Fluorouracil (5-FU)
• GW776 (GW776 (776C85))
• Leucovorin (folinic acid)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Lymphoma, Neoplasms | Phase 1 | Status: COMPLETED